Survival rate and its influencing factors of HIV/AIDS with antiretroviral therapy in Shangluo
10.19485/j.cnki.issn2096-5087.2020.01.005
- VernacularTitle:商洛市艾滋病抗病毒治疗病例生存率及影响因素分析
- Author:
YANG Xiaodan
1
;
TIAN Chunyan
;
LI Yueyou
;
MAO Zhaoming
;
JIA Wentao
Author Information
1. Shangluo Center for Disease Control and Prevention
- Publication Type:Journal Article
- Keywords:
HIV/AIDS highly active antiretroviral therapy survival analysis influencing factors
- From:
Journal of Preventive Medicine
2020;32(1):18-21
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the survival status and influencing factors of HIV/AIDS patients after receiving highly active antiretroviral therapy（HAART）in Shangluo,Shaanxi Province,so as to provide evidence for improving the effect of HAART.
Methods:HIV/AIDS patients who received HAART for the first time in Shangluo from 2010 to 2018 were investigated. Life table method was used to analyze the survival rate,mortality rate and median survival time of the subjects. A proportional hazards model was used to analyze the influencing factors for the survival time of HIV/AIDS patients.
Results:A total of 286 HIV/AIDS patients were collected,and 27 of them died of AIDS. After HAART,the 1-year,cumulative survival rates of less than 1 year,4 years and 8 years were 93.95%,89.71% and 88.39%,respectively. The results of multivariate proportional hazards regression analysis showed that the patients aged 30 years when first received HAART had higher risk of death than those aged 18-29 years（RR：4.208-24.095,95%CI：1.219-79.491）;patients with AIDS had higher risk of death than those with HIV（RR=38.590, 95%CI：15.451-96.382）;patients by homosexual transmission（RR=3.425,95%CI：1.385-8.470）and non-sexual transmission（RR=10.299,95%CI：3.602-29.446）had higher risk of death than those by heterosexual transmission;patients with baseline CD4+T lymphocytes number of 200/μL and more（RR：0.133-0.170,95%CI：0.048-0.604）had lower risk of death than those with less than 200/μL.
Conclusions :The survival rate of HIV/AIDS patients in Shangluo after receiving HAART is relatively high. Age at the start of treatment,course of disease,route of infection and the number of CD4+T lymphocytes at baseline are the influencing factors of survival time.
